期刊文献+

Cyclin D1蛋白表达与卵巢癌转移相关性研究 被引量:5

Association between Cyclin D1 protein expression and metastasis of ovarian cancer
下载PDF
导出
摘要 目的:探讨细胞周期蛋白(CyclinD1)表达与卵巢癌转移的相关性和CyclinD1与P21WAF1、P53蛋白的关系。方法:应用蛋白免疫印迹技术(Westernblot)检测61例人卵巢癌组织及7例卵巢非癌组织中CyclinD1、P53及P21WAF1蛋白的表达。结果:卵巢癌组织中CyclinD1和P53蛋白表达率均明显高于卵巢非癌组织(P<0.05);P21WAF1蛋白表达卵巢癌组织低于卵巢非癌组织(P>0.05)。CyclinD1与P53及P21WAF1蛋白表达与卵巢癌组织类型无关(P>0.05)。P21WAF1蛋白表达与卵巢癌的临床分期相关(P<0.05),CyclinD1、P53蛋白表达与卵巢癌的临床分期无关(P>0.05)。CyclinD1、P53及P21WAF1蛋白表达与卵巢癌转移相关(P<0.05)。结论:CyclinD1蛋白表达与卵巢癌肿瘤转移相关,CyclinD1与P21WAF1、P53蛋白在卵巢癌发生、发展中可能有一定作用,但不起协同作用。 Objective:To investigate the association between Cyclin D1 and metastasis and determine the relationship between Cyclin D1 proteins expression and P21 WAF1?P53 proteins in ovarian cancer.Methods:Cyclin D1,P21 WAF1 and P53 proteins were detected from 61 ovarian carcinoma and 7 ovarian tissues without cancer by using Western blot method.Results:The positive rate of Cyclin D1 and P53 proteins expression in cases with ovarian cancer were significantly higher than those in without cancer tissues(P<0.05),the expression of P21 WAF1 protein was not.No significant correlation were found between expression of Cyclin D1,P53 and P21 WAF1 proteins and histological grade(P>0.05).However, the expression of P21 WAF1 protein was correlated with clinical stages(P<0.05), but Cyclin D1 and P53 proteins were not(P>0.05).The expression of Cyclin D1,P53 and P21 WAF1 protein in ovarian carcinoma were related to metastasis(P<0.05).Conclusion:The expression of Cyclin D1 protein was correlated with tumor metastasis in ovarian cancer.Cyclin D1 and P21 WAF1,P53 proteins may play a role in the formation and development in ovarian cancer, but they may not act cooperatively in ovarian cancer.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2005年第7期501-503,共3页 Chinese Journal of Immunology
关键词 卵巢肿瘤 CYCLIN D1 P21^WAF1 P53 Ovarian neoplasm Cyclin D1 P21 WAF1 P53
  • 相关文献

参考文献5

  • 1Le Marchand L, Seifried A, Lum-Jones A et al.Association of the cyclin D1,A870G polymorphism with advanced colorectal cancer [J].JAMA,2003;290(21):2843-2848.
  • 2Sherr C J, Roberts J M. CDK inhibitor: positive and negative regulator of G -phase progression [J]. Genes Dev,1999;13(12):1501-1512.
  • 3郑美莲,区宝祥,龙江斌,邓满泉,陈丽珍,梁启万,李辉梅.estern印迹杂交分析p53蛋白在人鼻咽癌中的表达及其意义[J].中国免疫学杂志,2000,16(4):205-207. 被引量:5
  • 4Hartwell L H, Kastan M B. Cell cycle control and cancer [J]. Science,1994;266(5192):1821-1828.
  • 5Gebhart J B, Roche P C, Keeney G L et al.Assessment of inhibit and P53 in granulose cell tumor of the ovary [J].Gynecol Oncol,2000;72(2):232-236.

二级参考文献2

  • 1Gan H,Cancer Res,1994年,54卷,16期,43页
  • 2Sun Y,Proc Nat Acad Sci SUA,1992年,89卷,14期,6516页

共引文献4

同被引文献48

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部